SCHEMBL29530397

SCHEMBL29530397

[2H]C([2H])([2H])Oc1ccncc1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP2E1 P05181 1/20 0.44
CYP2A6 P11509 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2B6 P20813 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
CLK1 P49759 5/20 0.36
CLK2 P49760 5/20 0.36
DYRK1A Q13627 5/20 0.36
CLK4 Q9HAZ1 5/20 0.36
DYRK1B Q9Y463 4/20 0.36
CLK3 P49761 3/20 0.36
CDK5 Q00535 3/20 0.36
CDK5R1 Q15078 3/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29530749 0.87 CYP1A2 (0.56) CYP1A2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL564720 0.87 CYP1A2 (0.56) CYP1A2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL11640386 0.76 ALDH1A1 (0.40) CYP1A2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL3785439 0.76 ALDH1A1 (0.42) CYP1A2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL365309 0.75 XDH (0.45) ALDH1A1SMN1; SMN2HTT
SCHEMBL30751778 0.75 XDH (0.45) ALDH1A1SMN1; SMN2HTT
SCHEMBL249967 0.75 CA12 (0.49) CYP1A2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL29579481 0.73 GAA (0.55) ALDH1A1SMN1; SMN2KDM4EUSP2
SCHEMBL564715 0.72 ALDH1A1 (0.40) CYP1A2CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL29530507 0.72 CLK1 (0.44) CYP1A2CYP2E1CYP2A6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116940354-A Fused heteroaryl compounds and their use as CaMKII inhibitors 卡都瑞恩医药股份有限公司 2023-10-24 CN disclosed
EP-4216948-A1 FUSED HETEROARYL COMPOUNDS AND THEIR USE AS CAMKII INHIBITORS Cardurion Pharmaceuticals, Inc. (US) 2023-08-02 EP disclosed
WO-2022067082-A1 FUSED HETEROARYL COMPOUNDS AND THEIR USE AS CAMKII INHIBITORS CARDURION PHARMACEUTICALS, LLC (US) 2022-03-31 WO disclosed